|
SEH1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.339200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.520100E-02 |
| Normal-vs-Stage2 |
7.489800E-01 |
| Normal-vs-Stage3 |
5.236000E-01 |
| Normal-vs-Stage4 |
3.364000E-01 |
| Stage1-vs-Stage2 |
1.232010E-01 |
| Stage1-vs-Stage3 |
2.011700E-02 |
| Stage1-vs-Stage4 |
8.959300E-03 |
| Stage2-vs-Stage3 |
8.843000E-01 |
| Stage2-vs-Stage4 |
6.731000E-01 |
| Stage3-vs-Stage4 |
7.238800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.443000E-01 |
| Normal-vs-AfricanAmerican |
4.514000E-01 |
| Normal-vs-Asian |
7.399000E-01 |
| Caucasian-vs-AfricanAmerican |
2.068400E-01 |
| Caucasian-vs-Asian |
5.767200E-01 |
| AfricanAmerican-vs-Asian |
9.540200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.412000E-01 |
| Normal-vs-Female |
9.137600E-02 |
| Male-vs-Female |
3.378000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.017200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.869000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.238400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.429800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.148600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.007000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.798600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.594200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.068400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.015600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.743170E-01 |
| Normal-vs-Grade 2 |
1.167880E-02 |
| Normal-vs-Grade 3 |
8.791800E-01 |
| Normal-vs-Grade 4 |
1.643340E-03 |
| Grade 1-vs-Grade 2 |
5.800400E-01 |
| Grade 1-vs-Grade 3 |
8.783900E-02 |
| Grade 1-vs-Grade 4 |
2.178300E-03 |
| Grade 2-vs-Grade 3 |
4.121400E-03 |
| Grade 2-vs-Grade 4 |
1.15019999968879E-07 |
| Grade 3-vs-Grade 4 |
1.879040E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.03870000001116E-06 |
| Normal-vs-ccB subtype |
5.898300E-03 |
| ccA subtype-vs-ccB subtype |
3.9190872769268E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.364000E-01 |
| Normal-vs-N1 |
3.944000E-01 |
| N0-vs-N1 |
3.174400E-01 |
|
|
